CABINET MEDICAL DU DR LIBOIS
ActiveCABINET MEDICAL DU DR LIBOIS has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €649k and a net result of €30k. Equity is growing by ~14% per year across the filed fiscal years. Its solvency ranks better than 38% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
75
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability58▲+9
Solvency73▲+4
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €45k at 30 days acceptable
Liquidity short (current ratio 0.53 against 0.88 in 2024; short-term debt: 16.8% and cash: 6.2% of total assets), and 51.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
48.5%
Return on assets
2.3%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
31 d late
2024
60 d late
2023
30 d late
2022
21 d early
2021
11 d early
2020
87 d late
2019
88 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€649k▲ 4.6%
2024 · €620k
2018: €285k
2019: €229k
2020: €196k
2021: €222k
2022: €572k
2023: €605k
2024: €620k
2018 → 2025
Total assets
€1.34M▼ 5.4%
2024 · €1.41M
2018: €1.37M
2019: €1.28M
2020: €1.20M
2021: €1.16M
2022: €1.47M
2023: €1.46M
2024: €1.41M
2018 → 2025
Net result
€30k▲ 79.4%
2024 · €17k
2018: €3k
2019: €-56k
2020: €-32k
2021: €25k
2022: €36k
2023: €35k
2024: €17k
2018 → 2025
Working capital
€-106k▼ 256%
2024 · €-30k
2018: €-336k
2019: €-374k
2020: €-366k
2021: €-327k
2022: €-295k
2023: €-282k
2024: €-30k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€222k-€572k▲ 158%€605k▲ 5.9%€620k▲ 2.5%€649k▲ 4.6%
Operating result€58k-€68k▲ 17.0%€84k▲ 23.0%€64k▼ 24.4%€76k▲ 19.6%
Net result€25k-€36k▲ 40.3%€35k▼ 1.4%€17k▼ 51.9%€30k▲ 79.4%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 20% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.34M
Fixed assets
€1.22M▲ 2.2%
Current assets
€119k▼ 46.4%
Equity and liabilities €1.34M
Equity
€649k▲ 4.6%
Debt
€690k▼ 13.2%
The debt ratio falls from 56.2% to 51.5%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€156k▲
2024 · €140k
Cash flow
€110k▲
2024 · €93k
Solvency
48.5%▲
2024 · 43.8%
Current ratio
0.53▼
2024 · 0.88
Quick ratio
0.53▼
2024 · 0.88
Debt / equity
1.06▼
2024 · 1.28
ROE
4.7%▲
2024 · 2.7%
ROA
2.3%▲
2024 · 1.2%
Interest coverage
4.43▲
2024 · 3.50
Debt
€690k▼
2024 · €795k
Debt ≤ 1 year
€225k▼
2024 · €251k
Debt > 1 year
€431k▼
2024 · €508k
Income taxes
€12k▲
2024 · €8k
Staff costs
€83k▲
2024 · €79k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.41M€1.34M▼
Fixed assets21/28€1.19M€1.22M▲
Tangible fixed assets22/27€1.19M€1.22M▲
Land and buildings22€1.15M€1.09M▼
Plant, machinery and equipment23€38k€125k▲
Furniture and vehicles24€5k€5k▼
Financial fixed assets28€3k€3k=
Current assets29/58€221k€119k▼
Amounts receivable within one year40/41€29k€25k▼
Trade receivables40€21k€16k▼
Other amounts receivable41€8k€9k▲
Cash at bank and in hand54/58€184k€83k▼
Deferred charges and accrued income490/1€9k€10k▲
Equity and liabilities
Total equity and liabilities10/49€1.41M€1.34M▼
Equity10/15€620k€649k▲
Contributions10/11€547k€547k=
Reserves13€73k€102k▲
Distributable reserves133€73k€102k▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€795k€690k▼
Amounts payable after more than one year17€508k€431k▼
Financial debts170/4€258k€181k▼
Other amounts payable178/9€250k€250k=
Amounts payable within one year42/48€251k€225k▼
Current portion of amounts payable after more than one year42€75k€77k▲
Trade debts44€3k€6k▲
Suppliers440/4€3k€6k▲
Taxes, remuneration and social security45€26k€20k▼
Taxes450/3€11k€6k▼
Remuneration and social security454/9€15k€15k▲
Other amounts payable47/48€148k€122k▼
Accrued charges and deferred income492/3€35k€34k▼
Income statement
Code20242025
Remuneration, social security and pensions62€79k€83k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€76k€80k▲
Other operating charges640/8€6k€6k▼
Gross operating margin9900€225k€245k▲
Operating profit (loss)9901€64k€76k▲
Financial income75/76B€1k€1k▲
Recurring financial income75€1k€1k▲
Financial charges65/66B€40k€35k▼
Recurring financial charges65€40k€35k▼
Profit (loss) for the period before taxes9903€25k€42k▲
Income taxes67/77€8k€12k▲
Profit (loss) for the period9904€17k€30k▲
Profit (loss) for the period to be appropriated9905€17k€30k▲
Appropriation of the result
Profit (loss) to be appropriated9906€17k€30k▲
Transfer from equity791/2€0-
Transfer to equity691/2€15k€29k▲
To other reserves6921€15k€29k▲
Profit to be distributed694/7€2k€2k▼
Return on contributions (dividend)694€2k€2k▼
The notes to these accounts (16 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
29-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 60 days late
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
10-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Highest result since 2018net €36k ▲40.3%
Net result €36k, the highest in the series.
31-12
Financial
Equity above €500kEq €572k ▲158%
2 profitable years in a row build equity to €572k.
20-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Back to profitnet €25k
Net result €25k after 2 loss-making years.
31-12
Financial
Equity above €200kEq €222k ▲12.9%
Equity rises from €196k to €222k.
26-10
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 87 days late
2020
27-10
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 88 days late
2019
31-12
Financial
Weakest financial yearnet €-56k ▼1756%
Net result drops to €-56k, the lowest in the series; recovery starts the following year.
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 30 days late
2018
31-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 31 days late
2017
31-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Thuin · 2 establishment units since 2001
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Sentier Maquet(BST) 36531 ThuinGround area
2,945 m²
Building footprint
264 m²
Volume, LiDAR
1,391 m³
2 parcels, Wallonia · tallest building 9.2 m, ±2 floors. Linked by address, not a title deed.
2 establishment units
Rue de Gozée 542, 6110 Montigny-le-Tilleul
since 20012.229.154.921
Sentier Maquet(BST) 3, 6531 Thuin
since 20012.229.155.317
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 56010B0090/00S000 | Wallonia | 1,772 m² | 1 · 6 m² | 2.6 m · 1 fl. |
| 52048D0063/00F033 | Wallonia | 1,173 m² | 1 · 258 m² | 9.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr.Koen De Feyter
BE 0865.769.837
Nijlen · Eq €649k
Dr. Jan De Vlieger
BE 0725.813.188
Waasmunster · Eq €649k
DOKTER JAN POELMAN
BE 0472.043.174
Gent · Eq €648k
DR ROBERT BOLDERMAN
BE 0741.802.451
Harelbeke · Eq €650k
HAPATTA
BE 0476.757.770
Beerse · Eq €648k
Of 16,628 companies in sector 86220 we hold annual accounts for 7,974. 6,221 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded30-04-2001
Fiscal year end31-12
Activities, NACEBEL
85120
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 25 filingsAddress and cadastre registers
Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
3 entriesE-mail:py.libois@gmail.com
Phone:071/51.68.93
Phone:071/59.57.85